Tag Archives: ALS
Research Update in the Fight Against ALS
| New Gene Mutation Discovery By ALS Association Consortium
is Major Breakthrough in Lou Gehrig’s Disease Research, a report from The ALS Association’s National Office Feb. 26, 2009
|In one of the most significant breakthroughs in the recent history of ALS research, a consortium of scientists organized and funded by The ALS Association has discovered a new gene, ALS6 (Fused in Sarcoma), responsible for about 5 percent of the cases of inherited ALS.The discovery will provide important clues to the causes of inherited ALS, which accounts for 10 percent of all cases, and sporadic ALS, which occurs in individuals with no family history of the disease and accounts for the other 90 percent of cases diagnosed.
“This is a momentous discovery in furthering our understanding of ALS,” said Lucie Bruijn, Ph.D., senior vice president of Research and Development at The ALS Association. “A new gene provides a new piece of the puzzle we can use to shed light on why ALS develops, and where to focus our efforts on creating new treatments and finding a cure.”The results of this groundbreaking research are published in the Friday, February 27 issue of the prestigious journal Science. The project was led by Tom Kwiatkowski M.D., Ph.D., at Massachusetts General Hospital, and Robert Brown, M.D., of the University of Massachusetts School of Medicine, and ALS Association-funded researchers Caroline Vance, Ph.D., and Christopher Shaw, M.D., of Kings College in London.The project was supported by a consortium of leading ALS researchers from around the world, formed as part of The Association’s Gene Identification Project. Their success reflects an unprecedented effort to accelerate the search for genetic mutations linked to all forms of ALS.
Dr. Brown noted, “We are particularly delighted because our trans-Atlantic consortium has pursued the chromosome 16 gene for more than six years. The ALS Association has been an all-important partner in this search. This discovery should lead to new cell and animal models of ALS, which will accelerate drug development.” “Global partnerships between investigators and funding agencies, such as the Motor Neuron Disease Association in the United Kingdom, are crucial to making these kinds of breakthroughs,” Dr. Bruijn commented. “This finding has opened up a whole new avenue of research and has the potential to uncover a common mechanism for most forms of ALS.”
The gene mutations were first identified by Dr. Kwiatkowski and were immediately confirmed by Dr. Vance, who also demonstrated abnormal accumulations of the mutant protein in cells cultured in the laboratory and the motor neurons of people carrying FUS mutations.
The gene, called FUS (“fused in sarcoma”), normally carries out multiple functions within motor neurons. These include regulating how gene messages (called messenger RNAs) are created, modified, and transported in order to build proteins. Some of these same functions also are performed by another gene called TARDPB encoding the protein TDP43, and mutations in the TDP-43 gene were recently linked to ALS as well.
“The fact that these two genes help perform the same function suggests that problems in this function may be critical in the development of ALS,” Dr. Bruijn said. “More research into exactly how these two genes work could ultimately lead to new treatments that are effective in slowing or stopping the progression of ALS and extending the lives of people with the disease.”
The mutations in the ALS6 gene were identified by detailed genetic sequencing in several families with an inherited form of ALS (familial ALS). Normally, the ALS6 protein works in the cell’s nucleus, but the mutations caused it to instead cluster outside the nucleus. Further work will be needed to determine precisely how this leads to ALS. With the gene in hand, scientists will be able to create cell and animal models containing the mutated gene, to examine in detail how the mutation operates and how it causes ALS.
“This suggests there may be a common mechanism underlying motor neuron degeneration,” according to Dr. Shaw. Motor neurons are nerve cells in the brain and spinal cord that control muscles. Motor neurons degenerate in ALS.
This is the second ALS-causing gene to be discovered in the past 12 months. SOD1, discovered in 1993, accounts for 20 percent of inherited cases of the disease. Mutations in the TARDP gene account for another four to five percent. The only well-defined causes of ALS are genetic. In both inherited and sporadic ALS, the disease symptoms and pathology are the same.
The possibility that ALS may be caused by several factors is the rationale for The Association’s policy of funding multiple genetic projects around the world and encouraging these leading geneticists to work together and share information to help locate disease-linked genes for faster, more accurate scientific results. By funding research on a global level, The Association helps put together “genetic pieces” of the ALS puzzle.
“Through our support of research such as this study, The ALS Association is committed to finding the causes of ALS, and using that knowledge to develop a cure as rapidly as possible,” Dr. Bruijn said. “We will build on the discovery of this new gene to carry that effort forward.”
ALS: Courage, Hope
“A Latter-Day Gehrig Survives, and He Demands to Be Heard,” link to a story about ALS from the New York Times
A few people you meet will have a huge impact on your life, even when you don’t realize it at the time. Keith Worthington was such a person. I met Worthington in 1982. His courage and dedication greatly affected me, but I had no idea then how his mission would later be so important to my family.
I was assigned to write a news release about a new center for a disease I knew little about: ALS. Frankly, at the time I was glad that meeting him was just part of my job. I was grateful not to have any personal acquaintance with the disease he was fighting. I’d heard the story about Lou Gehrig retiring from baseball years ago because of a paralyzing disease that was later named after him, but when I met Worthington I saw the full expression of that disease. Worthington was totally paralyzed and on a ventilator. ALS is a terrible, progressive neurodegenerative disease, and there isn’t a cure. Yet, he radiated cheerfulness.
Worthington was at the University of Kansas Medical Center, where I worked, to help open a new ALS Research Center. When he was diagnosed, he found little help or information anywhere, and he created, with his wife Sue’s help, an organization to help people with ALS and to raise money for research. That organization, which later joined the national ALS Association, is 30 years old this year and is named the Keith Worthington chapter. It’s one of more than 40 ALS Association chapters nationwide.
Worthington died two years after I met him, but I didn’t forget him or his courage to help people even when he knew he would never benefit himself. When my father was diagnosed with ALS in 1995, I felt punched in the gut, shocked, in denial. I immediately thought of Worthington and knew the fate that awaited my father. But I also knew that because of Worthington, there were care, support and equipment resources available to my father.
The Keith Worthington chapter has many devoted supporters, including baseball legend George Brett, who was Worthington’s friend, and golf legend Tom Watson, whose long-time friend and caddie Bruce Edwards died from ALS.